Article
RAD51 overexpression is a negative prognostic marker for colorectal adenocarcinoma
15 Oct 2012
Abstract excerpt
RAD51 is the central protein in the homologous recombination pathway and is therefore of great relevance in terms of both therapy resistance as well as genomic stability. By using a tissue microarray analysis of 1,213 biopsies taken from colorectal adenocarcinomas (CRCs), we investigated whether RAD51 expression can be used as a prognostic marker as well as potential associations between this and the expression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
